Media Requests
Please send all media-related inquiries and interview requests to mediarelations@lls.org.
An LLS representative will respond as soon as possible.
Kite Pharma and LLS Collaborate on CAR T-Cell Therapy for Lymphoma
Contact: Andrea Greif
(914) 821-8958 (p)
(914) 772-3027 (c)
andrea.greif@lls.org
Santa Monica, Calif., and White Plains, NY: July 1, 2015 – Kite Pharma, Inc., KITE, +2.77% and The Leukemia & Lymphoma Society (LLS) announced today that they have entered into a partnership to enhance the development of Kite's lead product candidate, KTE-C19, for the treatment of patient...
LLS Applauds Data from Celator Study of CPX-351 for High-Risk AML Patients
Contact: Andrea Greif
(914) 821-8958 (p)
(914) 772-3027 (c)
andrea.greif@lls.org
White Plains, N.Y. (June 24, 2015) – Interim data released today by Celator Pharmaceuticals regarding its study of CPX-351, a special formulation of two standard chemotherapy drugs, to treat elderly patients with high-risk acute myeloid leukemia (AML), is a positive advance for patients with few options fo...
LLS Sorry to Learn of Maryland Governor’s Lymphoma Diagnosis
Contact: Andrea Greif
(914)821-8958 (p)
(914)772-3027 (c)
andrea.greif@lls.org
White Plains, NY (June 22, 2015) – The Leukemia & Lymphoma Society (LLS) was sorry to learn this afternoon that Maryland Gov. Larry Hogan has been diagnosed with non-Hodgkin lymphoma (NHL).
His diagnosis is B-cell NHL, which is a diverse group of blood cancers that develop in the lymphatic system. While it ...
Leukemias With ALK Mutations Identified, May Respond to ALK Inhibitors
This news release is being distributed by the Knight Cancer Institute at Oregon Health & Science University. The research is partially funded by The Leukemia & Lymphoma Society.
Contact: Elisa Williams (OHSU)
(971) 344-5441
willieli@ohsu.edu
Philadelphia, PA (June 1, 2015) — Mutations in the ALK gene were identified in the tumors of two leukemia patients, and laboratory studies i...
Bart Sichel, CMO of Burlington Stores, Elected to LLS Board of Directors
For Immediate Release
Contact: Andrea Greif
Tel: (914) 821-8958
Cell: (914) 772-3027
Andrea.greif@lls.org
White Plains, N.Y. (April 29, 2015) - Bart Sichel, executive vice president and chief marketing officer at Burlington Stores, has been elected to the national board of directors of The Leukemia & Lymphoma Society (LLS). His term will be effective July 1, 2015 and will conclude ...
Timex Joins The Race Against Time to Accelerate Cancer Cures Through Partnership with LLS
MIDDLEBURY, CT, April 20, 2015 - Timex®, the world's leading global watch manufacturer, is proud to announce today its partnership with The Leukemia & Lymphoma Society as a National Sponsor of The Leukemia Cup Regatta. The Leukemia Cup Regatta is a thrilling series of 45 sailing events in North America that combine the joy of boating with the important task of raising money to cure cancers. Throughout 2015, T...
"Nashville" Star Charles Esten Brings Light to the Dark World of Cancer
Contact: Marcie Klein
Marcie.Klein@lls.org
(914) 821-8205
White Plains, NY, April 13, 2015 - Every three minutes someone in the U.S. is diagnosed with a blood cancer. No one knows this better than "Nashville" star Charles Esten and his wife Patty. Esten's 15-year-old daughter, Addie, was diagnosed with leukemia at age 2 ½. Naturally, their world was turned upside down. But, they quickly le...
PhRMA and LLS Report More Than 240 Medicines in Development to Treat Leukemia, Lymphoma and Other Blood Cancers
FOR IMMEDIATE RELEASE
Contact: Tina Stow
tstow@phrma.org
(202) 835-3581
Washington, D.C. (April 10, 2015) - America's biopharmaceutical research companies are currently developing more than 240 medicines for leukemia, lymphoma, myeloma and other forms of blood cancer, including more targeted treatment options for patients. These collaborative efforts to move research forward are detailed in a ...